Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Apr 15, 2013
Company News
Houghten deal
...totaling $750,000 to be paid on the third, fourth and fifth anniversaries of the transaction.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Jun 18, 2001
Strategy
Reinventing chemistry
...branch out has not protected everyone. Thus Trega Biosciences Inc . (San Diego, Calif., formerly
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Apr 21, 1997
Company News
Houghten drug discovery news
...Biosciences Inc . on May 1. Its common shares will trade under the symbol "TRGA."
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Jan 20, 1997
Company News
Houghten other research news
...receptor and other MC receptors, reduces body weight, blood glucose, and insulin levels in animals.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Jan 13, 1997
Company News
Houghten, Chugai deal
...of interest, the company will develop and commercialize any discoveries and pay royalties to Chugai.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Dec 9, 1996
Clinical News
HP 228 cytokine regulator data
...doses were tested, given twice a day for 14 days in the double-blind, placebo-controlled study.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Nov 18, 1996
Company News
Houghten deal
...will resign as HPIP's chief technical officer, but will remain on HPIP's board.(HPIP earnings, B13.)
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Oct 14, 1996
Company News
Houghten drug discovery news
...and withheld certain considerations from Dickman and Thompson. HPIP said the charges are without merit.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Sep 30, 1996
Company News
Magainin, Houghten deal
...representing the fair value of the issued shares. Magainin Pharmaceuticals Inc. (MAGN), Plymouth Meeting, Penn.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Sep 23, 1996
Clinical News
Houghten regulatory update
...San Diego, Calif.). HPIP has licensed the technology for its internal and collaborative chemistry program.
Houghten Pharmaceuticals Inc.
...
Read More
Items per page:
10
1 - 10 of 30
BioCentury
|
Apr 15, 2013
Company News
Houghten deal
...totaling $750,000 to be paid on the third, fourth and fifth anniversaries of the transaction.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Jun 18, 2001
Strategy
Reinventing chemistry
...branch out has not protected everyone. Thus Trega Biosciences Inc . (San Diego, Calif., formerly
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Apr 21, 1997
Company News
Houghten drug discovery news
...Biosciences Inc . on May 1. Its common shares will trade under the symbol "TRGA."
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Jan 20, 1997
Company News
Houghten other research news
...receptor and other MC receptors, reduces body weight, blood glucose, and insulin levels in animals.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Jan 13, 1997
Company News
Houghten, Chugai deal
...of interest, the company will develop and commercialize any discoveries and pay royalties to Chugai.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Dec 9, 1996
Clinical News
HP 228 cytokine regulator data
...doses were tested, given twice a day for 14 days in the double-blind, placebo-controlled study.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Nov 18, 1996
Company News
Houghten deal
...will resign as HPIP's chief technical officer, but will remain on HPIP's board.(HPIP earnings, B13.)
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Oct 14, 1996
Company News
Houghten drug discovery news
...and withheld certain considerations from Dickman and Thompson. HPIP said the charges are without merit.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Sep 30, 1996
Company News
Magainin, Houghten deal
...representing the fair value of the issued shares. Magainin Pharmaceuticals Inc. (MAGN), Plymouth Meeting, Penn.
Houghten Pharmaceuticals Inc.
...
Read More
BioCentury
|
Sep 23, 1996
Clinical News
Houghten regulatory update
...San Diego, Calif.). HPIP has licensed the technology for its internal and collaborative chemistry program.
Houghten Pharmaceuticals Inc.
...
Read More
Items per page:
10
1 - 10 of 30
Previous page
Next page